Heart stasis removal regeneration method and heart health assessment method after stasis removal

Abstract

The invention relates to the technical field of heart stasis removal, in particular to a heart stasis removal regeneration method and a heart health assessment method after stasis removal. The method comprises the following steps: S1, performing medical evaluation on a patient, and determining whether the patient is suitable for heart stasis removal or not; s2, according to the specific condition of a patient, determining an area needing key treatment, smearing special gel on the selected treatment area, and performing blood-letting puncture; s3, the negative pressure device is started, the negative pressure intensity is gradually increased to a preset value, and meanwhile vital sign changes of the patient are closely monitored; s4, accelerating discharge of pathological substances in the blood of the patient by using pulses with specific frequency; s5, after the negative pressure preset time and the frequency preset time are reached, the negative pressure is slowly reduced until the negative pressure is completely closed; and S6, measuring the cardiovascular state of the patient, and comparing data before and after treatment. According to the design, discharge of pathological substances in blood is accelerated by utilizing pulses with specific frequency, blood circulation is improved by combining negative pressure treatment, and heart health recovery can be effectively promoted.

Description

Technical Field

[0001] The present invention relates to the technical field of cardiac blood stasis removal, and in particular to a cardiac blood stasis removal and regeneration method and a method for evaluating cardiac health after blood stasis removal. Background Art

[0002] Heart disease generally refers to diseases that affect the structure and function of the heart. Coronary artery disease (CAD) is one of the most common heart diseases. The accumulation of plaques in the coronary arteries leads to narrowing or blockage of blood vessels, affecting the heart's blood supply, which may lead to serious consequences such as angina pectoris and myocardial infarction. Myocardial ischemia refers to insufficient blood supply to the myocardium, resulting in myocardial cell hypoxia and metabolic disorders. This situation may be caused by a variety of factors such as coronary artery disease, hypertension, and anemia. Heart failure is a chronic disease characterized by a weakened heart pumping function that cannot meet the body's metabolic needs. These diseases may lead to obstructed blood circulation, which in turn affects the function of organs throughout the body. Blood stasis treatment, that is, promoting the discharge of pathological substances in the body through physical or drug means, thereby improving blood circulation, is an indispensable part of heart disease treatment. Comprehensive, provide heart blood stasis regeneration methods and heart health assessment methods after blood stasis removal. Summary of the invention

[0003] The purpose of the present invention is to provide a method for removing blood stasis and regenerating the heart and a method for evaluating heart health after blood stasis removal, so as to solve the problem of heart congestion raised in the above-mentioned background technology.

[0004] To achieve the above object, the present invention aims to provide a method for removing blood stasis and regenerating the heart and a method for evaluating heart health after blood stasis removal, comprising the following steps:

[0005] S1. Conduct a medical assessment on the patient to determine whether the patient is suitable for cardiac evacuation;

[0006] S2. According to the patient's specific condition, determine the area that needs to be treated, apply special gel to the selected treatment area and perform acupuncture;

[0007] S3. Turn on the negative pressure device and gradually increase the negative pressure intensity to a predetermined value while closely monitoring the patient's vital signs.

[0008] S4. Use pulses of specific frequency to accelerate the discharge of pathological substances in the patient's blood;

[0009] S5. After reaching the preset negative pressure time and frequency time, slowly reduce the negative pressure until it is completely closed;

[0010] S6. Measure the patient's cardiovascular status and compare the data before and after treatment.

[0011] As a further improvement of the present technical solution, in S1, the medical assessment of the patient includes traditional Chinese medicine diagnosis, heart rate detection, medical history assessment, physical examination and auxiliary examination.

[0012] As a further improvement of the technical solution, in S2, according to the specific conditions of the patient, the area that needs to be treated intensively is determined, and a special gel is applied to the selected treatment area and acupuncture is performed, which includes the following steps:

[0013] S2.1. Determine the specific location of the heart and surrounding microvascular dense areas based on the results of imaging examinations and TCM diagnosis;

[0014] S2.2. Use a sterile marker to mark the skin area that needs to be treated.

[0015] S2.3. Select gel according to the requirements of the treatment device and the characteristics of the patient's skin;

[0016] S2.4. Clean the skin of the treatment area with sterile saline to remove oil and dirt, and gently dry the skin with sterile gauze.

[0017] S2.5. Take an appropriate amount of m grams of gel and apply it evenly on the marked treatment area;

[0018] S2.6. Perform bloodletting in the selected treatment area;

[0019] S2.7. Ask the patient how he feels after pricking. If the patient feels any pain, apply topical lidocaine gel evenly on the area after pricking. Ask the patient if he feels any discomfort. If there is any abnormality, make timely adjustments and observe the patient's reaction to lidocaine.

[0020] As a further improvement of the technical solution, in S3, the negative pressure device is turned on, and the negative pressure intensity is gradually increased to a predetermined value, while closely monitoring the changes in the patient's vital signs, including the following steps:

[0021] S3.1. Check the power supply, pipeline connection and sealing of the negative pressure device, check whether there are any wounds caused by pricking, set the initial parameters of the negative pressure device in advance according to the treatment plan and the specific situation of the patient, and prepare the vital signs monitoring equipment;

[0022] S3.2, placing the contact surface of the negative pressure device on the treatment area where the gel has been applied, and before placing the negative pressure device, performing denoising on the ECG signal using discrete wavelet transform;

[0023] S3.3. Set the initial negative pressure intensity, observe the patient's response to the negative pressure, and gradually increase the negative pressure intensity according to the preset increase rate until it reaches the predetermined value;

[0024] S3.4. During the process of increasing negative pressure, continuously monitor the display parameters of the negative pressure device, use the adaptive control algorithm to dynamically adjust the rate of increase and final intensity of negative pressure, and closely monitor the patient's vital signs. If any abnormality is found in the patient, immediately stop the negative pressure treatment and release the negative pressure;

[0025] S3.5. After reaching the predetermined negative pressure intensity, continue the negative pressure treatment according to the maintenance time set in the treatment plan.

[0026] As a further improvement of the technical solution, in S3.2, the discrete wavelet transform is:

[0027]

[0028] Among them, W s(j,k) represents the wavelet coefficient; s(n) represents the original ECG signal; ψ j,k(n) represents the discrete wavelet basis function; N represents the length of the ECG signal; n represents the index of the ECG signal length; j represents the scale parameter; k represents the translation parameter.

[0029] As a further improvement of the technical solution, in S3.4, the adaptive control algorithm is:

[0030]

[0031] Where u(t) represents the output of the controller; K p Represents proportional gain; K i Indicates the integral gain; K d represents the differential gain; a(t) represents the error; t represents the time point; c represents a small time increment; represents the error integral from time 0 to time t; represents the rate of change of error; d represents the differential sign.

[0032] As a further improvement of the technical solution, in S4, using pulses of a specific frequency to accelerate the discharge of pathological substances in the patient's blood includes the following steps:

[0033] S4.1. Select a treatment device with a specific frequency pulse, and pre-set the pulse frequency, amplitude, duration and interval according to the treatment plan and the patient's specific conditions;

[0034] S4.2. Place the contact surface of the pulse device on the treatment area where the gel has been applied.

[0035] S4.3, set the initial frequency and amplitude, observe the patient's response to the pulse, and gradually increase the pulse intensity according to the preset increase rate until it reaches the predetermined value;

[0036] S4.4. During the pulse increase process, continuously monitor the display parameters of the device;

[0037] S4.5. Continuously monitor the patient's vital signs. If any abnormality is found, immediately stop the pulse therapy and release the negative pressure.

[0038] S4.6. After reaching the predetermined pulse intensity, continue the pulse treatment according to the maintenance time set in the treatment plan.

[0039] As a further improvement of the technical solution, in S5, after reaching the predetermined negative pressure time and the predetermined frequency time, the negative pressure is slowly reduced until it is completely closed, including the following steps:

[0040] S5.1. Determine whether treatment has been completed for the scheduled period of time;

[0041] S5.2, first stop the pulse device;

[0042] S5.3. Set the rate of negative pressure reduction according to the treatment plan and the patient's specific conditions;

[0043] S5.4. Use an exponential decay function to gradually reduce the negative pressure intensity until the negative pressure device is completely turned off.

[0044] As a further improvement of the technical solution, in S5.4, the exponential decay function is:

[0045] P(t)=P f +(P 0 -P f ) -γt ;

[0046] Among them, P 0 Indicates the initial negative pressure intensity; P f represents the target negative pressure intensity; t represents the time point; γ represents the attenuation constant; and e represents the base of the natural logarithm.

[0047] As a further improvement of the technical solution, in S6, measuring the patient's cardiovascular status and comparing the data before and after treatment include the following steps:

[0048] S6.1. Ask the patient whether he / she feels any discomfort after treatment;

[0049] S6.2. Measure the patient's basic vital signs and compare the data before and after treatment;

[0050] S6.3. Use electrocardiogram to detect changes in the pattern of cardiac electrical activity and assess cardiac function;

[0051] S6.4. Use ultrasound imaging to observe cardiac structure and function, especially myocardial contractility and valvular function;

[0052] S6.5. Detect changes in relevant blood indicators;

[0053] S6.6. Observe the patient's appearance, listen to his voice, smell his body odor, and use pulse diagnosis to determine the circulation of Qi and blood and the function of internal organs.

[0054] Compared with the prior art, the present invention has the following beneficial effects:

[0055] 1. In this method of cardiac blood stasis removal and regeneration and the method of evaluating cardiac health after blood stasis removal, pulses of a specific frequency are used to accelerate the discharge of pathological substances in the blood, and negative pressure therapy is combined to improve blood circulation, which can effectively promote the recovery of cardiac health. After treatment, a detailed health assessment, including vital sign measurement, electrocardiogram testing, ultrasound imaging, and blood index testing, can be used to comprehensively evaluate the treatment effect and ensure that the patient's heart function is significantly improved. This method not only helps to remove harmful substances from the blood, but also enhances the heart's pumping function and overall metabolic capacity, thereby accelerating the heart's recovery process.

[0056] 2. In the heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal, by gradually increasing the negative pressure intensity and pulse frequency and closely monitoring the changes in the patient's vital signs, the treatment parameters can be adjusted in real time to ensure the safety of the treatment process. This method of precise control and real-time monitoring greatly reduces the risks that may occur during the treatment process and improves the overall safety of the treatment. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1 The figure is a flow chart of the overall method of the present invention. DETAILED DESCRIPTION

[0058] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0059] Example: See Figure 1 As shown, this embodiment provides a method for removing blood stasis and regenerating the heart and a method for evaluating heart health after blood stasis removal, comprising the following steps:

[0060] S1. Conduct a medical assessment on the patient to determine whether the patient is suitable for cardiac evacuation;

[0061] In this embodiment, the medical evaluation of the patient includes traditional Chinese medicine diagnosis (including pulse diagnosis, inspection, palpation, percussion, etc.), heart rate detection, medical history assessment (detailed understanding of the patient's medical history, including previous history of heart disease, surgical history, medication use, etc.), physical examination (conducting a comprehensive physical examination, especially heart auscultation, blood pressure measurement, etc.) and auxiliary examinations (referring to the results of imaging examinations such as electrocardiogram, echocardiogram, CT or MRI to understand the specific conditions of the heart and surrounding tissues).

[0062] S2. According to the patient's specific condition, determine the area that needs to be treated, apply special gel to the selected treatment area and perform acupuncture;

[0063] In this embodiment, according to the specific conditions of the patient, the area that needs to be treated intensively is determined, and a special gel is applied to the selected treatment area and acupuncture is performed, which includes the following steps:

[0064] S2.1. Determine the specific location of the heart and surrounding microvascular dense areas based on imaging examination results and TCM diagnosis results. Common treatment areas include both sides of the sternum and intercostal areas;

[0065] S2.2. Use a sterile marker pen to mark the areas that require focused treatment on the skin to ensure accuracy during the treatment process;

[0066] S2.3. Select gel according to the requirements of the treatment equipment and the characteristics of the patient's skin. Commonly used gels have good conductivity and biocompatibility to reduce skin damage and improve treatment effects;

[0067] S2.4. Use sterile saline or mild disinfectant (such as iodine) to clean the skin in the treatment area to remove oil and dirt, ensure that the skin is clean, and gently dry the skin with sterile gauze to ensure that the treatment area is dry;

[0068] S2.5. Take an appropriate amount of m grams of gel or lubricant and apply it evenly on the marked treatment area. Apply it gently to avoid excessive force that may damage the skin. Make sure that the application area is slightly larger than the marked treatment area to ensure that the gel is fully covered during the treatment. The thickness of the application should be moderate, generally 1-2 mm, to ensure good contact between the negative pressure device and the skin. At the same time, avoid excessive thickness that affects the treatment effect. Carefully check whether the applied gel is evenly distributed to ensure that there is no omission or accumulation;

[0069] S2.6. Perform bloodletting in the selected treatment area to promote the discharge of pathological substances;

[0070] S2.7. Ask the patient how he feels after pricking. If the patient feels any pain, use an appropriate amount of topical lidocaine gel and apply it evenly on the area after pricking to relieve the patient's pain or discomfort. Ask the patient if he feels any discomfort. If there is any abnormality, make timely adjustments and observe the patient's reaction to lidocaine to ensure that there is no allergic or other adverse reaction.

[0071] S3. Turn on the negative pressure device and gradually increase the negative pressure intensity to a predetermined value while closely monitoring the patient's vital signs.

[0072] In this embodiment, negative pressure therapy can promote local blood circulation by generating negative pressure in the treatment area, which helps to increase blood flow velocity, improve microcirculation, and thus accelerate the discharge of pathological substances in the blood; turning on the negative pressure device, gradually increasing the negative pressure intensity to a predetermined value, and closely monitoring the changes in the patient's vital signs, including the following steps:

[0073] S3.1. Check the power supply, pipeline connection and sealing of the negative pressure device to ensure that the device is in normal working condition. Check whether there are wounds or bleeding points caused by pricking, and ensure that these areas have been properly treated (if there is an open wound after pricking, avoid directly contacting the negative pressure device with the wound to avoid infection or other complications. Consider using a protective film to cover the wound before placing the negative pressure device). According to the treatment plan and the specific situation of the patient, pre-set the initial parameters of the negative pressure device, including the initial negative pressure intensity, increase rate, etc., prepare ECG monitors, blood pressure monitors, blood oxygen saturation monitors and other vital signs monitoring equipment, and ensure that they are working properly;

[0074] S3.2. Place the contact surface of the negative pressure device on the treatment area where the gel or lubricant has been applied, ensure that it fits tightly and there is no leakage, press the start button of the negative pressure device to start negative pressure treatment, and use discrete wavelet transform to denoise the ECG signal before placing the negative pressure device;

[0075] Furthermore, ECG signals are often interfered by various noises during the acquisition process, such as muscle activity noise, electromagnetic interference, baseline drift, etc. These noises will seriously affect the quality of the signal and the accuracy of subsequent analysis. Discrete wavelet transform denoising can effectively remove these noises and improve the quality of ECG signals. During negative pressure treatment, the patient's ECG activity needs to be monitored in real time. Denoising can ensure that the monitoring equipment accurately captures the changes in ECG signals, detects potential abnormalities in time, and ensures the safety and effectiveness of treatment. Wavelet transform can well preserve the details and transient characteristics of the signal during the denoising process, which is particularly important for ECG signals, because transient changes in ECG signals often contain important physiological information. Discrete wavelet transform is:

[0076]

[0077]

[0078] Among them, W s(j,k) represents the wavelet coefficient, i.e., the characteristics of the signal at different scales j and positions k; s(n) represents the original ECG signal, i.e., the ECG signal without denoising; ψ j,k(n) represents the discrete wavelet basis function, which is used to decompose the signal into components of different scales and positions; N represents the length of the ECG signal, that is, the number of sampling points; n represents the index of the length of the ECG signal; j represents the scale parameter, that is, the frequency resolution of the ECG signal; k represents the translation parameter, that is, the time resolution of the ECG signal; represents the scale factor, which is used to maintain energy conservation; represents the index after time scaling and translation, indicating the changes of the signal at different scales and positions;

[0079] S3.3. Set the initial negative pressure intensity (e.g. -20 mmHg), observe the patient's response to the negative pressure, and gradually increase the negative pressure intensity according to the preset increase rate (e.g. 5 mmHg per minute) until it reaches a predetermined value (e.g. -50 mmHg to -80 mmHg, the specific value depends on the treatment plan and the patient's condition). The gradual increase in negative pressure intensity can more effectively promote blood circulation and accelerate the discharge of pathological substances.

[0080] S3.4. During the process of increasing negative pressure, continuously monitor the display parameters of the negative pressure device to ensure that the negative pressure intensity gradually increases as expected, use an adaptive control algorithm to dynamically adjust the rate of increase and final intensity of the negative pressure, and closely monitor the patient's vital signs. If the patient is found to have abnormalities (arrhythmia, a sharp drop in blood pressure, decreased blood oxygen saturation, severe discomfort, etc.), immediately stop the negative pressure treatment and release the negative pressure;

[0081] Furthermore, during the negative pressure treatment, the patient's vital signs may change, such as heart rate, blood pressure and blood oxygen saturation. The adaptive control algorithm can monitor these vital signs in real time and dynamically adjust the rate of increase and final intensity of negative pressure according to the patient's specific response to ensure the safety of the treatment process. Different patients have different tolerance and response to negative pressure treatment. The adaptive control algorithm can dynamically adjust the negative pressure parameters according to the specific situation of each patient to make the treatment more personalized and effective, thereby optimizing the treatment effect. By dynamically adjusting the rate of increase and final intensity of negative pressure, the patient's discomfort during the treatment process can be reduced, the comfort of the treatment can be improved, and the patient's compliance can be increased. The adaptive control algorithm is:

[0082]

[0083] Where u(t) represents the output of the controller, that is, the negative pressure intensity that needs to be adjusted at time t; Kp Represents the proportional gain, which determines the influence of the current error on the control output; K i Represents the integral gain, which determines the influence of past error accumulation on the control output; K d represents the differential gain, which determines the degree of influence of the error change rate on the control output; a(t) represents the error, that is, the difference between the target heart rate and the actual heart rate, or the difference between the target blood pressure and the actual blood pressure; t represents the time point; c represents a small time increment;

[0084] It represents the error integral from time 0 to time t, reflecting the past error accumulation; It represents the rate of change of error, reflecting the speed at which the error changes over time; d represents the differential sign;

[0085] S3.5. After reaching the predetermined negative pressure intensity, continue the negative pressure treatment according to the maintenance time set in the treatment plan (e.g., 15-30 minutes).

[0086] S4. Use pulses of specific frequency to accelerate the discharge of pathological substances in the patient's blood;

[0087] In this embodiment, using pulses of a specific frequency to accelerate the discharge of pathological substances in the patient's blood includes the following steps:

[0088] S4.1. Select a treatment device with a specific frequency pulse, ensure that the frequency range and amplitude of the device meet the treatment requirements, ensure that the power supply, connecting wires, sensors and other components of the device are intact, and the device is in normal working condition. According to the treatment plan and the specific conditions of the patient, pre-set the frequency, amplitude, duration and interval of the pulse (using pulses of a specific frequency can stimulate vasodilation and increase local blood flow, thereby speeding up blood flow, which is conducive to carrying more pathological substances to the liver, kidneys and other organs for metabolism and excretion);

[0089] S4.2. Place the contact surface of the pulse device on the treatment area where the gel has been applied, ensuring a tight fit without leakage. If the device is equipped with a sensor, connect it to the designated monitoring point, ensuring good contact between the sensor and the skin, and also avoid the wound area after puncture.

[0090] S4.3. Set the initial frequency and amplitude (e.g., frequency is 10 Hz, amplitude is 1 mm), observe the patient's response to the pulse, and gradually increase the pulse intensity according to the preset increase rate (e.g., frequency increases by 1 Hz per minute, amplitude increases by 0.1 mm), until it reaches the predetermined value (e.g., frequency is 50 Hz, amplitude is 5 mm, the specific value depends on the treatment plan and patient condition);

[0091] S4.4. During the pulse increase process, continuously monitor the display parameters of the device to ensure that the frequency and amplitude gradually increase as expected;

[0092] S4.5. Continuously monitor the patient's vital signs. If any abnormality is found in the patient (arrhythmia, sharp drop in blood pressure, decreased blood oxygen saturation, severe discomfort, etc.), immediately stop the pulse treatment and release the negative pressure;

[0093] S4.6. After reaching the predetermined pulse intensity, continue the pulse treatment according to the maintenance time set in the treatment plan (e.g., 15-30 minutes).

[0094] S5. After reaching the preset negative pressure time and frequency time, slowly reduce the negative pressure until it is completely closed;

[0095] In this embodiment, after reaching the predetermined negative pressure time and the predetermined frequency time, slowly reducing the negative pressure until it is completely closed includes the following steps:

[0096] S5.1. Determine whether the treatment has reached the predetermined time or target (e.g., 30 minutes or the negative pressure intensity has reached a predetermined value);

[0097] S5.2, first stop the pulse device;

[0098] S5.3. Set the rate of decrease of negative pressure (e.g., 5 mmHg per minute) according to the treatment plan and the patient's specific condition.

[0099] S5.4. Use an exponential decay function to gradually reduce the negative pressure intensity until the negative pressure device is completely closed;

[0100] Furthermore, by gradually reducing the negative pressure intensity through an exponential decay function, it can be ensured that the negative pressure smoothly transitions from the maximum value to zero. This smooth transition helps to avoid physiological reactions caused by the sudden release of negative pressure, such as a sudden drop in blood pressure and arrhythmia; gradually reducing the negative pressure intensity can reduce the impact on the tissues in the treatment area and avoid skin damage, bleeding or other adverse reactions caused by the sudden release of negative pressure; the smooth negative pressure reduction process helps to consolidate the treatment effect and ensure that the blood circulation in the treatment area continues to maintain a good state during the gradual reduction of negative pressure, further promoting the discharge of pathological substances and tissue repair; the exponential decay function is:

[0101] P(t)=P f +(P 0 -P f ) -γt ;

[0102] Among them, P 0 Indicates the initial negative pressure intensity; P f represents the target negative pressure intensity; t represents the time point; γ represents the attenuation constant. It is calculated that T represents the total time; e represents the base of the natural logarithm.

[0103] S6. Measure the patient's cardiovascular status and compare the data before and after treatment;

[0104] In this embodiment, measuring the cardiovascular status of the patient and comparing the data before and after treatment include the following steps:

[0105] S6.1. Ask the patient whether he / she feels any discomfort after treatment, such as whether symptoms such as chest tightness and shortness of breath have improved;

[0106] S6.2. Measure basic vital signs such as blood pressure and heart rate, and compare the data before and after treatment;

[0107] S6.3. Use electrocardiogram to detect changes in the pattern of cardiac electrical activity and assess cardiac function;

[0108] S6.4. Use ultrasound imaging to observe cardiac structure and function, especially myocardial contractility and valvular function;

[0109] S6.5. Detect changes in relevant blood indicators, such as myocardial enzyme levels and inflammatory markers, to understand the extent of heart damage and repair, with special attention paid to the recovery of the puncture site, including whether there is redness, swelling, signs of infection, etc.;

[0110] S6.6. Observe the patient's complexion, tongue (tongue texture and tongue coating), eyes, skin and other external manifestations (for example, observe whether the tongue texture is dark purple, whether the sublingual veins are varicose, whether the complexion is pale or dull), listen to the patient's voice, smell the body odor (for example, listen to whether the patient's voice is low and weak, smell whether there is any unusual odor), and use pulse diagnosis (feeling the pulse) to determine the circulation of qi and blood and the function of internal organs (for example, determine whether there is blood stasis, insufficient heart qi, etc. through the pulse).

[0111] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments, and the above embodiments and descriptions are only preferred examples of the present invention, and are not intended to limit the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of the present invention to be protected.

Claims

1. A method for removing blood stasis and regenerating the heart and a method for evaluating heart health after blood stasis removal, characterized in that: The following steps are involved: S1. Conduct a medical assessment on the patient to determine whether the patient is suitable for cardiac evacuation; S2. According to the patient's specific condition, determine the area that needs to be treated, apply special gel to the selected treatment area and perform acupuncture; S3. Turn on the negative pressure device and gradually increase the negative pressure intensity to a predetermined value while closely monitoring the patient's vital signs. S4. Use pulses of specific frequency to accelerate the discharge of pathological substances in the patient's blood; S5. After reaching the preset negative pressure time and frequency time, slowly reduce the negative pressure until it is completely closed; S6. Measure the patient's cardiovascular status and compare the data before and after treatment.

2. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 1, characterized in that: In S1, the medical assessment of the patient includes traditional Chinese medicine diagnosis, heart rate monitoring, medical history assessment, physical examination and auxiliary examinations.

3. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 2, characterized in that: In S2, according to the specific conditions of the patient, the area that needs to be treated intensively is determined, and a special gel is applied to the selected treatment area and acupuncture is performed, which includes the following steps: S2.

1. Determine the specific location of the heart and surrounding microvascular dense areas based on the results of imaging examinations and TCM diagnosis; S2.

2. Use a sterile marker to mark the skin area that needs to be treated. S2.

3. Select gel according to the requirements of the treatment device and the characteristics of the patient's skin; S2.

4. Clean the skin of the treatment area with sterile saline to remove oil and dirt, and gently dry the skin with sterile gauze. S2.

5. Take an appropriate amount of m grams of gel and apply it evenly on the marked treatment area; S2.

6. Perform bloodletting in the selected treatment area; S2.

7. Ask the patient how he feels after pricking. If the patient feels any pain, apply topical lidocaine gel evenly on the area after pricking. Ask the patient if he feels any discomfort. If there is any abnormality, make timely adjustments and observe the patient's reaction to lidocaine.

4. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 3, characterized in that: In S3, the negative pressure device is turned on, and the negative pressure intensity is gradually increased to a predetermined value, while closely monitoring the changes in the patient's vital signs, including the following steps: S3.

1. Check the power supply, pipeline connection and sealing of the negative pressure device, check whether there are any wounds caused by pricking, set the initial parameters of the negative pressure device in advance according to the treatment plan and the specific situation of the patient, and prepare the vital signs monitoring equipment; S3.2, placing the contact surface of the negative pressure device on the treatment area where the gel has been applied, and before placing the negative pressure device, performing denoising on the ECG signal using discrete wavelet transform; S3.

3. Set the initial negative pressure intensity, observe the patient's response to the negative pressure, and gradually increase the negative pressure intensity according to the preset increase rate until it reaches the predetermined value; S3.

4. During the process of increasing negative pressure, continuously monitor the display parameters of the negative pressure device, use the adaptive control algorithm to dynamically adjust the rate of increase and final intensity of negative pressure, and closely monitor the patient's vital signs. If any abnormality is found in the patient, immediately stop the negative pressure treatment and release the negative pressure; S3.

5. After reaching the predetermined negative pressure intensity, continue the negative pressure treatment according to the maintenance time set in the treatment plan.

5. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 4, characterized in that: In S3.2, the discrete wavelet transform is: Among them, W s(j,k) represents the wavelet coefficient; s(n) represents the original ECG signal; ψ j,k(n) represents the discrete wavelet basis function; N represents the length of the ECG signal; n represents the index of the ECG signal length; j represents the scale parameter; k represents the translation parameter.

6. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 5, characterized in that: In S3.4, the adaptive control algorithm is: Where u(t) represents the output of the controller; K p Represents proportional gain; K i Indicates the integral gain; K d represents the differential gain; a(t) represents the error; t represents the time point; c represents a small time increment; represents the error integral from time 0 to time t; represents the rate of change of error; d represents the differential sign.

7. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 6, characterized in that: In S4, using pulses of a specific frequency to accelerate the discharge of pathological substances in the patient's blood includes the following steps: S4.

1. Select a treatment device with a specific frequency pulse, and pre-set the pulse frequency, amplitude, duration and interval according to the treatment plan and the patient's specific conditions; S4.

2. Place the contact surface of the pulse device on the treatment area where the gel has been applied. S4.3, set the initial frequency and amplitude, observe the patient's response to the pulse, and gradually increase the pulse intensity according to the preset increase rate until it reaches the predetermined value; S4.

4. During the pulse increase process, continuously monitor the display parameters of the device; S4.

5. Continuously monitor the patient's vital signs. If any abnormality is found, immediately stop the pulse therapy and release the negative pressure. S4.

6. After reaching the predetermined pulse intensity, continue the pulse treatment according to the maintenance time set in the treatment plan.

8. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 7, characterized in that: In S5, after reaching the predetermined negative pressure time and the predetermined frequency time, slowly reducing the negative pressure until it is completely closed includes the following steps: S5.

1. Determine whether treatment has been completed for the scheduled period of time; S5.2, first stop the pulse device; S5.

3. Set the rate of negative pressure reduction according to the treatment plan and the patient's specific conditions; S5.

4. Use an exponential decay function to gradually reduce the negative pressure intensity until the negative pressure device is completely turned off.

9. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 8, characterized in that: In S5.4, the exponential decay function is: P(t)=P f +(P0-P f )e -γt ; Where P0 represents the initial negative pressure intensity; P f represents the target negative pressure intensity; t represents the time point; γ represents the attenuation constant; and e represents the base of the natural logarithm.

10. The heart blood stasis removal and regeneration method and the heart health assessment method after blood stasis removal according to claim 9, characterized in that: In S6, measuring the patient's cardiovascular status and comparing the data before and after treatment includes the following steps: S6.

1. Ask the patient whether he / she feels any discomfort after treatment; S6.

2. Measure the patient's basic vital signs and compare the data before and after treatment; S6.

3. Use electrocardiogram to detect changes in the pattern of cardiac electrical activity and assess cardiac function; S6.

4. Use ultrasound imaging to observe cardiac structure and function, especially myocardial contractility and valvular function; S6.

5. Detect changes in relevant blood indicators; S6.

6. Observe the patient's external manifestations, listen to the patient's voice, smell the patient's body odor, and use pulse diagnosis to determine the circulation of qi and blood and the function of internal organs.

Images